A UK Multicentre Study of Haploidentical Stem Cell Transplantation in Patients With Haematological Malignancies
Inclusion Criteria:
- Aged 18-70 years of age with a diagnosis of a haematological malignancy that requires
an allograft, with a partially HLA mismatched donor (<5/6)
- Adequate organ function, defined as:
- LVEF >/= 45%
- DLCO, FEV1, FVC >/= 50% predicted
- Total bilirubin <35umol/L
- AST/ALT and alkaline phosphatase <5x upper limit of normal
- Serum creatinine within normal range, or if outside normal range for age, then
creatinine clearance >40ml/min/1.73m2
- Karnofsky performance score 60-100
- Donor available aged >/= 18 years
- Needs an urgent transplant where a suitable HLA matched sibling or unrelated donor is
unavailable in a timely manner.
- Donor available who is at least a 5/10 mathch
- Donor and recipient identical at at least one of the following alleles: HLA-A, HLA-B,
HLA-Cw, HLA-DRB1 or HLA-DQB1
- Patient must have received cytotoxic chemotherapy within 3 months of consent date
- Written informed consent
Exclusion Criteria:
- HLA matched, related donor able to donate
- Autologous haematopoietic stem cell transplant <3 months prior to enrolment
- Pregnancy or breastfeeding
- Uncontrolled bacterial, viral or fungal infection
- Serious psychiatric or psychological disorders
- Absence of, or inability to provide, informed consent
- Severe comorbidity (Seattle comorbidity score of 3 or more) or disease that prevents
treatment with chemotherapy
- Positive anti-donor HLA antibody
- Unable to receive 2Gy TBI (RIC pathway) or 12Gy TBI (MAC pathway)
- Patient with graft rejection following a previous allograft from either adult or cord
blood donors